Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same author

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Molecular therapy. Advances·2026
Same author

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same author

Therapeutic antibody delivery: vector tools to boost efficacy and affordability.

Frontiers in immunology·2026
Same author

Robust Functionality and Regulation of Selectively Expressed RNA as AAV Vectors and In Vitro Transcribed Molecules.

Pharmaceutics·2025

Related Experiment Video

Updated: Jul 5, 2026

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Recent developments in adeno-associated virus vector technology.

Hildegard Büning1, Luca Perabo, Oliver Coutelle

  • 1Clinic I for Internal Medicine, University of Cologne, Cologne, Germany. hildegard.buening@uk-koeln.de

The Journal of Gene Medicine
|May 3, 2008
PubMed
Summary
This summary is machine-generated.

Adeno-associated virus (AAV) is a leading gene therapy vector due to its safety and efficacy. This review covers AAV biology, vector technology advancements, and future challenges in gene delivery.

More Related Videos

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jul 5, 2026

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol
09:12

Isolation of Adeno-Associated Viral Vectors Through a Single-Step and Semi-Automated Heparin Affinity Chromatography Protocol

Published on: April 5, 2024

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Adeno-associated virus (AAV) is a single-stranded DNA parvovirus recognized for its nonpathogenicity and low immunogenicity.
  • Its stability and potential for site-specific integration without adverse effects position it as a premier gene therapy vector.
  • Ongoing research into AAV/host cell interactions is crucial for enhancing gene delivery efficacy.

Purpose of the Study:

  • To summarize current knowledge on the infectious biology of Adeno-associated virus (AAV).
  • To provide an overview of recent advancements in AAV vector technology.
  • To discuss the remaining challenges in the field of AAV-mediated gene therapy.

Main Methods:

  • Literature review of peer-reviewed articles on AAV infectious biology and vector technology.
  • Analysis of current research trends and developments in recombinant AAV (rAAV) vector applications.
  • Synthesis of information regarding AAV host cell interactions and gene delivery mechanisms.

Main Results:

  • AAV vectors are highly promising for gene therapy due to favorable safety and efficacy profiles.
  • Development of diverse recombinant AAV (rAAV) vector types aims to optimize gene transfer efficiency and specificity.
  • Understanding AAV-host cell interactions is key to improving rAAV-mediated gene delivery.

Conclusions:

  • Adeno-associated virus (AAV) vectors represent a significant advancement in gene therapy.
  • Continued research and development in AAV vector technology are essential for overcoming existing challenges.
  • Further investigation into AAV biology will enhance its therapeutic applications and safety.